Metraipolis › archive › dc_8f5b64db3bf2

Late-onset severe neutropenia in patients with relapsing remitting multiple sclerosis treated with ocrelizumab: case report and literature review — Europe PMC PMID:41357832

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41357832
DOI
10.3389/fnins.2025.1685209
License (as archived)
solo-consultazione
Archived
2026-11-08T09:30:27.621Z
SHA-256 of the archived text
a3e8eea6936200163dccbfdd1401016b9e927af8fbb785bfc6c1315202e847e4
Stable URL of this page
https://metraipolis.com/documento/dc_8f5b64db3bf2

How to cite

Late-onset severe neutropenia in patients with relapsing remitting multiple sclerosis treated with ocrelizumab: case report and literature review — Europe PMC PMID:41357832 — Europe PMC (en), https://europepmc.org/article/MED/41357832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f5b64db3bf2 (Metraipolis archive dc_8f5b64db3bf2, sha256 a3e8eea6936200163dccbfdd1401016b9e927af8fbb785bfc6c1315202e847e4)
BibTeX
@misc{dc8f5b64db3bf2,
  title = {Late-onset severe neutropenia in patients with relapsing remitting multiple sclerosis treated with ocrelizumab: case report and literature review — Europe PMC PMID:41357832},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41357832},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f5b64db3bf2; sha256 a3e8eea6936200163dccbfdd1401016b9e927af8fbb785bfc6c1315202e847e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357832. Agents can read the archived copy with the MCP tool read_document.